TA-CIN cervical intraepithelial neoplasia vaccine: Phase I

XEN reported results from its U.K. Phase I trial of TA-CIN vaccine to treat cervical intraepithelial neoplasia (CIN), another AGIN condition. The placebo-controlled dose-escalation study in 40 healthy...